Fuad El-Hibri, Chairman at Emergent BioSolutions Inc. (EBS), sold 40,000 shares at $102.66 ($4.1M) on 2020-09-10, disclosed to the SEC on 2020-09-11.
Open-market sale of $4.1M EBS by Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $102.80 | 20,000 | $2.1M | 50.0% |
| 2 | $102.66 | 20,000 | $2.1M | 50.0% |
| Total | $102.73 avg | 40,000 | $4.1M | 100% |
| Filing → |
| EBS | SELL | 2020-09-25 | $3.8M | — | Filing → |
| EBS | SELL | 2020-09-18 | $6.1M | — | Filing → |
| EBS | SELL | 2020-05-01 | $3.0M | — | Filing → |